[White Paper] Advanced Flow Cytometry – Rapid analysis for complex cell-based models 본문 #Cell Based Assays, #Drug Discovery, #Advanced Flow Cytometry, #Cell Viability, #Cell Proliferation, #Cytokine Analysis, #Antibody Binding, #Hybridoma Screening The use of cell-based assays for drug discovery has dramatically increase over the last decade, as researchers look to bridge the gap between the results observed in classical biochemical assays and clinical studies. Additionally, advances in our understanding of cell biology and the shift from universally applicable small molecule drugs towards precision medicine approaches and biotherapeutics has resulted in a move towards the use of cell based assays far earlier in the drug discovery workflow. Traditional cell-based approaches are however, not designed to handle the far larger sample sets and high throughput screening assays commonly required for early stage candidate identification. Download this white paper to learn more about: The detection and analysis technologies currently used in drug discovery The potential advantages and drawbacks of current technologies for early phase drug discovery How advanced flow cytometry addresses these challenges to deal with the demands of modern drug discovery pipelines. 목록 이전글 [White Paper] An Opportunity to Read How Researchers Are Investigating Alzheimer's Mysteries 다음글 [White Paper] Table-Top Robotic Systems